Global Preclinical Toxicology Service Market Growth (Status and Outlook) 2024-2030

Global Preclinical Toxicology Service Market Growth (Status and Outlook) 2024-2030

Preclinical Toxicology Service is one of the key steps in drug development to evaluate the safety, toxicity and potential adverse reactions of candidate drugs or treatment options. These services are usually performed before the drug enters clinical trials and cover acute, subchronic and chronic toxicity studies, as well as genotoxicity, carcinogenicity and reproductive toxicity assessments. The results of preclinical toxicology studies can help pharmaceutical companies and research institutions understand the safety characteristics of candidate drugs and decide whether to advance clinical trials.

The global Preclinical Toxicology Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Preclinical Toxicology Service Industry Forecast” looks at past sales and reviews total world Preclinical Toxicology Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Preclinical Toxicology Service sales for 2023 through 2029. With Preclinical Toxicology Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical Toxicology Service industry.

This Insight Report provides a comprehensive analysis of the global Preclinical Toxicology Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preclinical Toxicology Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preclinical Toxicology Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical Toxicology Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical Toxicology Service.

United States market for Preclinical Toxicology Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Preclinical Toxicology Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Preclinical Toxicology Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Preclinical Toxicology Service players cover Charles River Laboratories, Labcorp, Eurofins Scientific, PRA Health Sciences, Envigo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical Toxicology Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Genetic Toxicity Testing
Reproductive Toxicity Testing
Immunotoxicity Testing
Others

Segmentation by Application:
Biopharmaceutical Company
Research Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Genetic Toxicity Testing
Reproductive Toxicity Testing
Immunotoxicity Testing
Others

Segmentation by Application:
Biopharmaceutical Company
Research Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Labcorp
Eurofins Scientific
PRA Health Sciences
Envigo
WuXi AppTec
ICON
Syneos Health
Biosciences Laboratories
Toxikon
Intertek
Scantox

Please note: The report will take approximately 2 business days to prepare and deliver.